Professional Medical Expertise Co. vs Boston Scientific Corporation
A head-to-head of Professional Medical Expertise Co. (9574) and Boston Scientific Corporation (BSX) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 9574 | BSX |
|---|---|---|
| Market Cap | 287.00M SAR | $65.44B |
| P/E (TTM) | 7.05 | 18.42 |
| Forward P/E | — | 11.86 |
| P/S | 0.69 | 4.04 |
| P/B | 1.96 | 2.95 |
| EV/EBITDA | 6.19 | 16.91 |
| Dividend Yield | 122.00% | — |
| Profit Margin | 9.96% | 17.29% |
| Gross Margin | 44.17% | 69.01% |
| Operating Margin | 14.43% | 19.78% |
| Revenue Growth (YoY) | +38.00% | +11.58% |
| FCF Yield | — | 3.96% |
| Debt / Equity | 81.31 | 41.78 |
| Current Ratio | 1.55 | 1.90 |
Which is better: Professional Medical Expertise Co. or Boston Scientific Corporation?
- ✓Larger by market cap: Boston Scientific Corporation
- ✓Cheaper valuation (lower P/E): Professional Medical Expertise Co.
- ✓More profitable (net margin): Boston Scientific Corporation
- ✓Faster revenue growth: Professional Medical Expertise Co.
Very close — each leads on 5 metrics.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.